Finally, high expression of SH2D3A has been reported to enhance the progression of ovarian cancer [63], and downregulation of PHLDA2 has been reported to significantly inhibit the development of colorectal cancer through the PI3K/AKT signaling pathway [64]. Here, SH2D3A is linked to colorectal cancer.